Lupin Acquires Three Diabetes Trademarks from Boehringer Ingelheim to Enhance its Portfolio in India
Lupin Limited is an international pharmaceutical company, which announced today that it has acquired three anti-diabetes trademarks from Boehringer Ingelheim International GmbH: GIBTULIO, GIBTULIO MET, and AJADUO. This acquisition aims…